Brokerages Set athenahealth (ATHN) Target Price at $151.50

athenahealth (NASDAQ:ATHN) has earned a consensus recommendation of “Hold” from the twenty-eight analysts that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, eighteen have issued a hold rating and eight have assigned a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $152.64.

Several equities analysts have commented on the stock. Royal Bank of Canada restated a “hold” rating and issued a $160.00 price target on shares of athenahealth in a research note on Thursday, May 17th. ValuEngine downgraded shares of athenahealth from a “buy” rating to a “hold” rating in a research note on Friday, May 18th. Jefferies Group set a $160.00 price target on shares of athenahealth and gave the stock a “hold” rating in a research note on Thursday, May 17th. Deutsche Bank boosted their price target on shares of athenahealth from $160.00 to $170.00 and gave the stock a “hold” rating in a research note on Tuesday. Finally, Robert W. Baird boosted their price target on shares of athenahealth to $150.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 8th.

In related news, SVP Jonathan D. Porter sold 422 shares of the business’s stock in a transaction on Monday, May 7th. The shares were sold at an average price of $153.30, for a total value of $64,692.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Bradford Kyle Armbrester sold 2,235 shares of the business’s stock in a transaction on Friday, March 2nd. The shares were sold at an average price of $138.70, for a total transaction of $309,994.50. Following the completion of the sale, the senior vice president now directly owns 10,146 shares of the company’s stock, valued at $1,407,250.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 48,431 shares of company stock valued at $7,084,565. 2.90% of the stock is owned by corporate insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Alliancebernstein L.P. lifted its position in athenahealth by 1.8% in the fourth quarter. Alliancebernstein L.P. now owns 22,790 shares of the health services provider’s stock valued at $3,032,000 after acquiring an additional 400 shares during the last quarter. Amalgamated Bank raised its holdings in shares of athenahealth by 5.7% in the fourth quarter. Amalgamated Bank now owns 7,892 shares of the health services provider’s stock valued at $1,050,000 after buying an additional 427 shares during the last quarter. Guggenheim Capital LLC raised its holdings in shares of athenahealth by 16.9% in the first quarter. Guggenheim Capital LLC now owns 2,980 shares of the health services provider’s stock valued at $426,000 after buying an additional 430 shares during the last quarter. Flinton Capital Management LLC raised its holdings in shares of athenahealth by 62.2% in the first quarter. Flinton Capital Management LLC now owns 1,168 shares of the health services provider’s stock valued at $167,000 after buying an additional 448 shares during the last quarter. Finally, Riverhead Capital Management LLC raised its holdings in shares of athenahealth by 63.0% in the first quarter. Riverhead Capital Management LLC now owns 1,320 shares of the health services provider’s stock valued at $189,000 after buying an additional 510 shares during the last quarter.

Shares of athenahealth traded up $0.32, hitting $153.92, during trading on Monday, Marketbeat reports. The company’s stock had a trading volume of 3,429 shares, compared to its average volume of 835,797. The company has a market cap of $6.21 billion, a price-to-earnings ratio of 97.95, a price-to-earnings-growth ratio of 2.85 and a beta of 1.16. The company has a quick ratio of 2.71, a current ratio of 2.71 and a debt-to-equity ratio of 0.25. athenahealth has a fifty-two week low of $111.61 and a fifty-two week high of $158.66.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, April 26th. The health services provider reported $1.25 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.72 by $0.53. The business had revenue of $329.40 million during the quarter, compared to the consensus estimate of $318.13 million. athenahealth had a net margin of 6.77% and a return on equity of 13.01%. The company’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.32 earnings per share. analysts expect that athenahealth will post 2.92 EPS for the current year.

About athenahealth

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply